1. Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
2. . Research Methodology
1. Qualitative Research
1. Primary and Secondary Products
2. Quantitative Research
1. Primary and Secondary Products
3. Breakdown of Primary Research Respondents
1. Secondary Research
2. Primary Research
4. Breakdown of Primary Research Respondents, By Industry Participants
5. Market Breakdown & Data Triangulation
3. Executive Summary
4. U.S. IUD Market – Industry Insights
1. Industry Value Chain Analysis
2. DROC Analysis
1. Growth Drivers
2. Restraints
3. Opportunity
4. Challenges
3. Recent Developments
4. Regulatory Framework
5. Porter Five Forces Analysis
5. US IUD Market Overview

5.1. Market Size & Forecast by Value, 2017-2027

1. By Value (USD Million)
2. By Volume (Thousand Units)

5.2. Market Share & Forecast

1. By Type
1. Hormonal Intrauterine Device
2. Copper Intrauterine Device
2. .   By End-User
1. Hospitals
2. Gynaecology Centres
3. Community Healthcare Centres
6. US IUD Competitive Landscape
1. List of Key Players and Their Offerings
2. Market Share Analysis (2020)
3. Competitive Benchmarking, By Operating Parameters
7. IUD MARKET: Top 4 Company Ranking Analysis, 2020
8. Top 5 Brands Analysis in IUD Market
9. Impact of COVID-19 Across IUD Industry

10. List of IUD Clinical Trials

11. Which IUD is Right for Use

12. How much Does an IUD Cost (And Will Insurance Cover It)?

13. Insurance Coverage and Financing of IUDs

14.  Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

14.1. Bayer AG

14.2. Allergan PLC

14.3. Cooper Companies (CooperSurgical Inc)

15. Key Strategic Recommendations

 

*Financial details of unlisted companies will be available as per data availability in final deliverable

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable.

 

List of Figures.

 

Fig 1: U.S. IUDs Segmentation

Fig 2: U.S. IUDs Market Size, By Value (USD Million)

Fig 3: U.S. IUDs Market Share, By End-User, By Value (in %), 2020

Fig 4: U.S. IUD: Value Chain Analysis Market: Healthcare Industry Value Chain

Fig 5: Process of a Clinical Trial & Approval

Fig 6: Estimated numbers of women (Million) of reproductive age (15-49 years) using various contraceptive methods, 1994 and 2019

Fig 7 - Estimated IUD prevalence of individual contraceptive methods among women of reproductive age (15-49 years), 2019

Fig 8:  U.S. Women Healthcare Density

Fig 9: Porters Five Forces Analysis

Fig 10: U.S. IUDs Market Size, By Value (USD Million), 2017-2027

Fig 11: U.S. IUDs Market Size, By Volume (Thousand Units), 2017-2027

Fig 12: U.S. IUDs Market Share (%), By Type, By Value, 2017-2027

Fig 13: U.S. IUDs Market Share (%), By Type, By Volume, 2017-2027

Fig 14: U.S. IUDs Market Share (%), By End-User, By Value, 2017-2027

Fig 15: U.S. IUDs Market Share (%), By End-User, By Volume, 2017-2027

Fig 16: List of Key Players and Their Offerings

Fig 17: U.S. IUDs: Market/Ranking Share Analysis, 2020

Fig 18: Use of Contraceptive Among Women Aged 18-49 at Risk of Unintended Pregnancy, 2017

Fig 19: Ranking of Leading Players in U.S. IUD Market

Fig 20: Top 5 Brands Analysis in IUD Market

Fig 21: % of Women's Reporting Delays/Cancellation During COVID-19 for Contraceptive and Other SRH Care

Fig 22: Tiered Discounts for Mirena Purchases

Fig 23: Tiered Discounts for Skyla Purchases

Fig 24: Tiered Discounts for Liletta Purchases

Fig 25: Tiered Discounts for ParaGard Purchases

 

List of Tables.

 

Table 1: Types of IUDs

Table 2: Types of IUDs, Their Years Effective and Use

Table 3: U.S. Government-Funded Family Planning/Reproductive Health (FP/RH) Interventions

Table 4: U.S. IUDs Market Size, By Type, By Value (USD Million), 2017-2027

Table 5: U.S. IUDs Market Size, By Type, By Volume (Thousand Units), 2017-2027

Table 6: U.S. IUDs Market Size, By End-Users, By Value (USD Million), 2017-2027

Table 7: U.S. IUDs Market Size, By End-Users, By Volume (Thousand Units), 2017-2027

Table 8: Competitive Benchmarking, by Operating Parameters

Table 9: List of IUD Clinical Trials

Table 10: Comparison Chart of IUS’s for Right Selection

Table 11: Comparison Chart of IUS’s for Right Selection

Table 12: IUD Brand Wise Average Cost Analysis, 2020

Table 13: Bayer AG Company Overview

Table 14: Bayer AG. Financial Analysis (USD Million)

Table 15: Abbvie Inc. Company Overview

Table 16: Abbvie Inc. Financial Analysis (USD Million)

Table 17: Cooper Companies (CooperSurgical Inc) Company Overview

Table 18: Cooper Companies (CooperSurgical Inc) Financial Analysis (USD Million)

Table 19: IUD Products Under Clinical Trials in the United States